From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD)
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
From Monovalent to Multivalent Vaccines, the Exploration for Potential Preventive Strategies Against Hand, Foot, and Mouth Disease (HFMD)
Authors
Keywords
-
Journal
VIROLOGICA SINICA
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-09-30
DOI
10.1007/s12250-020-00294-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Study of integrated protective immunity induced in rhesus macaques by the intradermal administration of a bivalent EV71-CA16 inactivated vaccine
- (2020) Shengtao Fan et al. VACCINE
- Muscle destruction caused by coxsackievirus A10 in gerbils: Construction of a novel animal model for antiviral evaluation
- (2020) Chen Chen et al. VIRUS RESEARCH
- Immunogenicity, safety, cross-reaction, and immune persistence of an inactivated enterovirus A71 vaccine in children aged from two months to 11 years in Taiwan
- (2019) Li-Min Huang et al. VACCINE
- Advances in Antigenic Peptide-Based Vaccine and Neutralizing Antibodies against Viruses Causing Hand, Foot, and Mouth Disease
- (2019) Mohd Anasir et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Hand, foot, and mouth disease associated with coxsackievirus A10: more serious than it seems
- (2019) Lianlian Bian et al. Expert Review of Anti-Infective Therapy
- Recombinant virus-like particle presenting a newly identified coxsackievirus A10 neutralization epitope induces protective immunity in mice
- (2019) Wenlong Dai et al. ANTIVIRAL RESEARCH
- An adult gerbil model for evaluating potential coxsackievirus A16 vaccine candidates
- (2019) Ping-Ping Yao et al. VACCINE
- Immune responses against enterovirus A71 infection: Implications for vaccine success
- (2019) Kam Leng Aw‐Yong et al. REVIEWS IN MEDICAL VIROLOGY
- Effectiveness and safety of an inactivated enterovirus 71 vaccine in children aged 6-71 months in a phase IV study
- (2019) Xuhua Guan et al. CLINICAL INFECTIOUS DISEASES
- A virus-like particle vaccine protects mice against coxsackievirus A10 lethal infection
- (2018) Yu Zhou et al. ANTIVIRAL RESEARCH
- The immunogenicity and protection effect of an inactivated coxsackievirus A6, A10, and A16 vaccine against hand, foot, and mouth disease
- (2018) Heeji Lim et al. VACCINE
- Recent development of enterovirus A vaccine candidates for the prevention of hand, foot, and mouth disease
- (2018) Chih-Yeu Fang et al. Expert Review of Vaccines
- T Cell Immunity To Enterovirus 71 Infection In Humans And Implications For Vaccine Development
- (2018) Pinn Tsin Isabel Yee et al. International Journal of Medical Sciences
- Characterization of an inactivated whole-virus bivalent vaccine that induces balanced protective immunity against coxsackievirus A6 and A10 in mice
- (2018) Zhenjie Zhang et al. VACCINE
- Protective Efficacies of Formaldehyde-Inactivated Whole-Virus Vaccine and Antivirals in a Murine Model of Coxsackievirus A10 Infection
- (2017) Zhenjie Zhang et al. JOURNAL OF VIROLOGY
- A Neonatal Murine Model of Coxsackievirus A6 Infection for Evaluation of Antiviral and Vaccine Efficacy
- (2017) Zhenjie Zhang et al. JOURNAL OF VIROLOGY
- A 3.0-Angstrom Resolution Cryo-Electron Microscopy Structure and Antigenic Sites of Coxsackievirus A6-Like Particles
- (2017) Jinhuan Chen et al. JOURNAL OF VIROLOGY
- Hepatitis B virus core particles containing multiple epitopes confer protection against enterovirus 71 and coxsackievirus A16 infection in mice
- (2017) Chunling Huo et al. VACCINE
- Pathologic and immunologic characteristics of coxsackievirus A16 infection in rhesus macaques
- (2017) Jingjing Wang et al. VIROLOGY
- Epitope-associated and specificity-focused features of EV71-neutralizing antibody repertoires from plasmablasts of infected children
- (2017) Kuan-Ying Arthur Huang et al. Nature Communications
- Effective in vivo therapeutic IgG antibody against VP3 of enterovirus 71 with receptor-competing activity
- (2017) Qiang Jia et al. Scientific Reports
- Persistent circulation of Coxsackievirus A6 of genotype D3 in mainland of China between 2008 and 2015
- (2017) Yang Song et al. Scientific Reports
- Yeast-produced recombinant virus-like particles of coxsackievirus A6 elicited protective antibodies in mice
- (2016) Yu Zhou et al. ANTIVIRAL RESEARCH
- Coxsackievirus A16-like particles produced in Pichia pastoris elicit high-titer neutralizing antibodies and confer protection against lethal viral challenge in mice
- (2016) Chao Zhang et al. ANTIVIRAL RESEARCH
- Establishment of an animal challenge model as a potency assay for an inactivated Enterovirus Type 71 vaccine
- (2016) Kun-Teng Wang et al. BIOLOGICALS
- Characterizing Enterovirus 71 and Coxsackievirus A16 virus-like particles production in insect cells
- (2016) Balaji Somasundaram et al. METHODS
- A novel inactivated enterovirus 71 vaccine can elicit cross-protective immunity against coxsackievirus A16 in mice
- (2016) Lisheng Yang et al. VACCINE
- Vesicular stomatitis virus-based vaccines expressing EV71 virus-like particles elicit strong immune responses and protect newborn mice from lethal challenges
- (2016) Qin Yan et al. VACCINE
- EV-A71 vaccine licensure: a first step for multivalent enterovirus vaccine to control HFMD and other severe diseases
- (2016) Qunying Mao et al. Emerging Microbes & Infections
- Ultrastructural Characterization of the Lower Motor System in a Mouse Model of Krabbe Disease
- (2016) Valentina Cappello et al. Scientific Reports
- Two-year efficacy and immunogenicity of Sinovac Enterovirus 71 vaccine against hand, foot and mouth disease in children
- (2015) Jing-Xin Li et al. Expert Review of Vaccines
- A new EV71 VP3 epitope in norovirus P particle vector displays neutralizing activity and protection in vivo in mice
- (2015) Liping Jiang et al. VACCINE
- Hexon-modified recombinant E1-deleted adenoviral vectors as bivalent vaccine carriers for Coxsackievirus A16 and Enterovirus 71
- (2015) Chao Zhang et al. VACCINE
- Efficacy of a Trivalent Hand, Foot, and Mouth Disease Vaccine against Enterovirus 71 and Coxsackieviruses A16 and A6 in Mice
- (2015) Elizabeth Caine et al. Viruses-Basel
- A Broadly Cross-protective Vaccine Presenting the Neighboring Epitopes within the VP1 GH Loop and VP2 EF Loop of Enterovirus 71
- (2015) Longfa Xu et al. Scientific Reports
- Novel recombinant chimeric virus-like particle is immunogenic and protective against both enterovirus 71 and coxsackievirus A16 in mice
- (2015) Hui Zhao et al. Scientific Reports
- Protection from lethal challenge in a neonatal mouse model by circulating recombinant form coxsackievirus A16 vaccine candidates
- (2014) J. Li et al. JOURNAL OF GENERAL VIROLOGY
- An Inactivated Enterovirus 71 Vaccine in Healthy Children
- (2014) Rongcheng Li et al. NEW ENGLAND JOURNAL OF MEDICINE
- Neutralizing antibodies can initiate genome release from human enterovirus 71
- (2014) Pavel Plevka et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A combination vaccine comprising of inactivated enterovirus 71 and coxsackievirus A16 elicits balanced protective immunity against both viruses
- (2014) Yicun Cai et al. VACCINE
- A virus-like particle based bivalent vaccine confers dual protection against enterovirus 71 and coxsackievirus A16 infections in mice
- (2014) Zhiqiang Ku et al. VACCINE
- The immunogenicity and protection effect of the BPL-inactivated CA16 vaccine in different animal systems
- (2014) Wen Qi An et al. Human Vaccines & Immunotherapeutics
- A Novel Universal Neutralizing Monoclonal Antibody against Enterovirus 71 That Targets the Highly Conserved “Knob” Region of VP3 Protein
- (2014) Tanja K. Kiener et al. PLoS Neglected Tropical Diseases
- Virus-like particles produced in Saccharomyces cerevisiae elicit protective immunity against Coxsackievirus A16 in mice
- (2013) Hui Zhao et al. APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
- A Strain-Specific Epitope of Enterovirus 71 Identified by Cryo-Electron Microscopy of the Complex with Fab from Neutralizing Antibody
- (2013) H. Lee et al. JOURNAL OF VIROLOGY
- Human IgG Subclasses against Enterovirus Type 71: Neutralization versus Antibody Dependent Enhancement of Infection
- (2013) Rui-Yuan Cao et al. PLoS One
- Transgenic mouse model for the study of enterovirus 71 neuropathogenesis
- (2013) Ken Fujii et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Virus-like particles for enterovirus 71 produced from Saccharomyces cerevisiae potently elicits protective immune responses in mice
- (2013) Hao-Yang Li et al. VACCINE
- Induction of protective immune responses against EV71 in mice by baculovirus encoding a novel expression cassette for capsid protein VP1
- (2012) Balraj Premanand et al. ANTIVIRAL RESEARCH
- Identification and characterization of a cross-neutralization epitope of Enterovirus 71
- (2011) Chia-Chyi Liu et al. VACCINE
- Neonatal rhesus monkey is a potential animal model for studying pathogenesis of EV71 infection
- (2011) Longding Liu et al. VIROLOGY
- Enterovirus 71 virus-like particle vaccine: Improved production conditions for enhanced yield
- (2010) Cheng-Yu Chung et al. VACCINE
- Sialylated glycans as receptor and inhibitor of enterovirus 71 infection to DLD-1 intestinal cells
- (2009) Betsy Yang et al. Virology Journal
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More